Serial #79260069
LIVE

Serial Number

79260069

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 4, 2019

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79260069 Trademark

Serial Number: 79260069 • Registration: 5946978

Serial #79260069 is a trademark filed by NOVARTIS AG on April 4, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 4, 2019

Registration Date

December 31, 2019

Published for Opposition

October 15, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 31, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 1, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Apr 14, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 14, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 31, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 12, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 25, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 25, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2019 NONP
ASSIGNED TO LIE
Sep 9, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 6, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2019 REAP
REFUSAL PROCESSED BY IB
Aug 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jul 13, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 26, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jun 25, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 21, 2019 MAFR
ASSIGNED TO EXAMINER
Jun 17, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 14, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 6, 2019 REPR